Home News & Events Events Events Page tools Share Share Share on FacebookShare on XShare on LinkedinShare on Bluesky Print Search Email Accessibility Filter events Filter events by clicking within the ‘Category’ drop-down list. Category - Any - Industry Webinars Workshop Previous 1 … 2 3 4 In this section In this section Press releases In the News Mediakit Facts and figures ICON spokespeople Awards Events Industry events ASCO 2026 Webinars Workshops Webinars Social media hub Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Related information: Solutions Webinars Solutions Industry events Solutions Workshops What's happening in ICON ICON Plc The FDA’s new support of a single study approach has drawn much discussion, raising questions as to whether conducting just one confirmatory study is a risky position for sponsors to take. In this blog, Andrew Garrett,... 15 May View post View webpage ICON Plc We’re gearing up for ISPOR 2026 - what HEOR or real world evidence challenges are you focused on this year? Stop by Booth \#1017 at #ISPORAnnual to exchange ideas and explore how ICON can support your evidence strategy... 15 May View post View webpage ICON Plc Risk-based monitoring isn’t about doing less. It’s about doing the right work, in the right place, at the right time – but that looks different for every study. As RBQM adoption accelerates, sponsors are moving beyond b... 15 May View post View webpage ICON Plc A key challenge in dermatology has been the lack of a simple, reliable, and standardized tool to measure nail psoriasis severity - particularly in clinical trials. A newly published study co-authored by ICON introduces t... 15 May View post View webpage ICON Plc Do you struggle to keep on top of regulatory changes affecting the world of medicine and medical device clinical trials? Join thousands of subscribers who have discovered the convenience of our free monthly publication b... 14 May View post View webpage ICON Plc Biosimilar formulation development is becoming more complex as patient-centric design, high concentration products and evolving regulatory expectations converge. In a recent PharmTech Q&A, ICON’s Kim Salgado and Venkat ... 14 May View post View webpage ICON Plc Reaching the right patients starts with the right sites. Connect with us at ASCO, booth \#35093, to learn how ICON expands site reach by activating patient dense regions and engaging high potential sites, including Acce... 14 May View post View webpage ICON Plc Meet the ICON team at booth \#26 during DIA China, taking place 13–16 May in Shanghai. ICON will be attending the conference and looks forward to connecting with peers to discuss perspectives on clinical development and... 14 May View post View webpage ICON Plc Are you working with NONMEM or PDx-Pop? Don’t miss the chance to connect with our team at PAGE in Croatia. Visit us at booth \#2 to: - Explore the latest features in NONMEM and PDx-Pop - Get expert insights on populati... 14 May View post View webpage ICON Plc The ICON team are at AAPS NBC. Stop by booth \#404 to discuss how our comprehensive bioanalytical and early clinical manufacturing solutions can support your research and development goals. https://www.aaps.org/nbc 13 May View post View webpage ICON Plc Menopausal vasomotor symptoms (VMS), including hot flashes and night sweats, are now understood to arise from estrogen‑deficiency–related dysregulation of hypothalamic KNDy neurons, leading to increased neurokinin B (NKB... 13 May View post View webpage ICON Plc We are proud to announce the opening of our new state‑of‑the‑art clinical research unit in San Antonio, Texas, and forthcoming satellite outpatient clinics in Houston, TX and Lawrence, KS. The new CRU integrates clinica... 13 May View post View webpage
